FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Parabolic Drugs IPO and Technofab IPO.
Parabolic Drugs IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Technofab IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Parabolic Drugs IPO | Technofab IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | ICICI Securities Limited Spa Capital Advisors Ltd |
Collins Stewart Inga Private Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Parabolic Drugs IPO is up to ₹200.00 Cr whereas the issue size of the Technofab IPO is up to ₹71.66 Cr. The final issue price of Parabolic Drugs IPO is ₹75.00 per share and of Technofab IPO is ₹240.00 per share.
Parabolic Drugs IPO | Technofab IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹75.00 per share | ₹230.00 per share |
Issue Price (Upper) | ₹85.00 per share | ₹240.00 per share |
Issue Price (Final) | ₹75.00 per share | ₹240.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 80 shares | 25 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 2,66,66,667 shares | 29,90,000 shares |
Issue Size Total (Amount) | up to ₹200.00 Cr | up to ₹71.66 Cr |
Parabolic Drugs IPO opens on Jun 14, 2010, while Technofab IPO opens on Jun 29, 2010. The closing date of Parabolic Drugs IPO and Technofab IPO is Jun 17, 2010, and Jul 02, 2010, respectively.
Parabolic Drugs IPO | Technofab IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jun 14, 2010 | Jun 29, 2010 |
Issue Close | Jun 17, 2010 | Jul 02, 2010 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Parabolic Drugs IPO P/E ratio is , as compared to Technofab IPO P/E ratio of .
Parabolic Drugs IPO | Technofab IPO | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 63.2% | 51% | ||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 46.5% | |||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||
ROCE | 6.21%% | |||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||
RoNW | 19.96%% | 38.2%% |
In the Parabolic Drugs IPO retail investors (RII) are offered 91,58,334 shares while in Technofab IPO retail investors are offered 91,58,334 shares. Qualified institutional buyers (QIB) are offered 1,30,83,333 shares in Parabolic Drugs IPO and 14,70,000 shares in Technofab IPO.
Parabolic Drugs IPO | Technofab IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 1,30,83,333 shares | 14,70,000 shares |
NII | 39,25,000 shares | 4,41,000 shares |
RII | 91,58,334 shares | 10,29,000 shares |
Employee | 5,00,000 shares | 50,000 shares |
Others | ||
Total | 2,66,66,667 shares | 29,90,000 shares |
Parabolic Drugs IPO subscribed 1.04x in total, whereas Technofab IPO subscribed 12.78x.
Parabolic Drugs IPO | Technofab IPO | |
---|---|---|
QIB (times) | 1.48x | 4.28x |
NII (times) | 1.20x | 48.85x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 0.40x | 10.03x |
Employee (times) | 0.11x | 1.10x |
Other (times) | ||
Total (times) | 1.04x | 12.78x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|